Empyrean Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Air Products & Chemicals
APD
|
+$106M |
| 2 |
CELG
Celgene Corp
CELG
|
+$96.2M |
| 3 |
Elanco Animal Health
ELAN
|
+$76.1M |
| 4 |
Fox Class B
FOX
|
+$53M |
| 5 |
Equitable Holdings
EQH
|
+$45.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$151M |
| 2 |
AABA
Altaba Inc
AABA
|
+$60.8M |
| 3 |
I
INTELSAT S. A.
I
|
+$32.6M |
| 4 |
CZR
Caesars Entertainment Corporation
CZR
|
+$19.7M |
| 5 |
TSRO
TESARO, Inc.
TSRO
|
+$16.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49% |
| 2 | Materials | 15.19% |
| 3 | Healthcare | 8.34% |
| 4 | Communication Services | 6.65% |
| 5 | Financials | 5.39% |
Similar funds
Empyrean Capital Partners's Q1 2019 Portfolio in Review
As of Q1 2019, Empyrean Capital Partners held 92 positions worth $2.19B, up 13% from $1.94B the previous quarter. Its ten largest holdings account for 57% of the portfolio.
Empyrean Capital Partners deployed $97.5M of net new capital in Q1 2019, opening 29 new positions and adding to 9 existing holdings. Its largest new stake was Air Products & Chemicals: 618,307 shares worth $118M.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 60% a quarter earlier, followed by Materials and Healthcare.
On the sell side, the largest reduction was Altaba Inc, an estimated $60.8M trimmed.
- Empyrean Capital Partners's largest Q1 2019 buy was Air Products & Chemicals: 618,307 shares worth $118M.
- Empyrean Capital Partners added most to Ashland in Q1 2019, an estimated $34.1M increase.
- Empyrean Capital Partners's biggest Q1 2019 reduction was Altaba Inc, cutting an estimated $60.8M.
- Empyrean Capital Partners fully exited Twenty-First Century Fox, Inc. Class B in Q1 2019, selling an estimated $151M.
- Empyrean Capital Partners's ten largest holdings make up 57% of its $2.19B portfolio in Q1 2019.
- Empyrean Capital Partners opened 29 new positions and closed 15 in Q1 2019.
- Empyrean Capital Partners's portfolio value rose 13% quarter-over-quarter to $2.19B.
Based on Empyrean Capital Partners's 13F filing for Q1 2019, filed 15 May 2019.